Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
NCT01786915
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Bendavia 10mg
DRUG:
Bendavia 50mg
DRUG:
Placebo
Sponsor
Stealth BioTherapeutics Inc.